Position in DYN
as of Mar 31, 2026
· filed May 20, 2026
Position Value
$28,236,858
-$22,911,759 QoQ
Shares Held
1,557,466
-40.4% QoQ
Ownership
1.09%
of shares outstanding
% of Portfolio
2.42%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Vivo Capital, LLC holds $1,160,013,312 across 42 Biotechnology names. DYN ranks #12 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ERAS |
Erasca, Inc.
|
12,151,480 | $196,610,946 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
338,895 | $109,188,580 | |
| 3 | TERN |
Terns Pharmaceuticals, Inc.
|
1,334,418 | $70,350,516 | |
| 4 | TRVI |
Trevi Therapeutics, Inc.
|
5,094,668 | $60,779,389 | |
| 5 | DBVT |
DBV Technologies S.A.
|
2,667,569 | $55,725,516 | |
| 6 | CMPX |
Compass Therapeutics, Inc.
|
9,545,466 | $50,495,515 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
2,154,780 | $45,077,997 | |
| 8 | SABS |
SAB Biotherapeutics, Inc.
|
11,420,000 | $43,738,600 |
All Filings in DYN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $28,236,858 | 1,557,466 | Shares | Sole | 2026-05-20 | |
| 2025-12-31 | $51,148,617 | 2,614,960 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $33,079,244 | 2,614,960 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,614,419 | 1,114,960 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $11,662,481 | 1,114,960 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $26,268,457 | 1,114,960 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $40,049,363 | 1,114,960 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $57,703,949 | 1,635,136 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $46,421,511 | 1,635,136 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $13,767,308 | 1,035,136 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $9,274,818 | 1,035,136 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $6,498,472 | 577,642 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,654,435 | 577,642 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,694,870 | 577,642 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $7,336,053 | 577,642 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,968,400 | 577,642 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $5,568,468 | 577,642 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $6,868,163 | 577,642 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $9,380,906 | 577,642 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $12,153,587 | 577,642 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $8,970,780 | 577,642 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $6,615,000 | 315,000 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $6,359,850 | 315,000 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||